Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- J. Joshua Smith, MD
Memorial Sloan Kettering Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
685 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- Centro Comprensivo de Cancer de Upr
San Juan, Puerto Rico
- Pan American Center for Oncology Trials Llc
San Juan, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Alaska Breast Care and Surgery Llc
Anchorage, Alaska, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Alaska Women'S Cancer Care
Anchorage, Alaska, United States
- Anchorage Associates in Radiation Medicine
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Kingman Regional Medical Center
Kingman, Arizona, United States
- Cancer Center at Saint Joseph'S
Phoenix, Arizona, United States
- Mayo Clinic Hospital in Arizona
Phoenix, Arizona, United States
- Mercy Hospital Fort Smith
Fort Smith, Arkansas, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California, United States
- Pcr Oncology
Arroyo Grande, California, United States
- Keck Medicine of Usc Buena Park
Buena Park, California, United States
- Providence Saint Joseph Medical Center/disney Family Cancer Center
Burbank, California, United States
- Mercy Cancer Center - Carmichael
Carmichael, California, United States
- Mercy San Juan Medical Center
Carmichael, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Mercy Cancer Center - Elk Grove
Elk Grove, California, United States
- Washington Hospital
Fremont, California, United States
- City of Hope at Irvine Lennar
Irvine, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Los Angeles General Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Mercy Cancer Center
Merced, California, United States
- Providence Queen of the Valley
Napa, California, United States
- Usc Norris Oncology/hematology-Newport Beach
Newport Beach, California, United States
- Saint Joseph Hospital - Orange
Orange, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Mercy Cancer Center - Rocklin
Rocklin, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Dec 2022
- Primary completion
- 30 Sept 2026
- Completion
- 30 Sept 2033
- Last update posted
- 8 Sept 2025
- Registered enrollment
- 783
- Registry id
- NCT05610163
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.